Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Le Pari De Pascal and The Zen of CLARITAS

<< Previous

Bullboard Posts

Next >>

Comment by Dude51on Aug 27, 2021 9:05pm

112 Views

Post# 33777647

RE:RE:Le Pari De Pascal and The Zen of CLARITAS

How many do you own Scotty? Nothing by my dd. So fucc off and don't come back. If someone wants to post some of their dd what the fucc does it matter to you. Most of us are grown up here and can make our own destiny we do not need some snot nosed pos basher trying to help us. Clearly yur not here to help so just fucc off why don't you? You should do some dd on R-107 and find critiziem there. But you can't because it's a sound product. You fucc you Scotty you POS, mind your own fuccen business assole.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario